| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
STK10 |
STK10: Uncharacterized protein STK10 |
0.41 |
Evidence |
|
| IL7R |
IPI00549649 |
CD6 |
CD6: T-cell differentiation antigen CD6 precursor |
0.41 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
CST7 |
CST7: Cystatin-F precursor |
0.41 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.41 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
SELL |
SELL, LNHR, LYAM1: L-selectin precursor |
0.41 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
0.41 |
Evidence |
|
| SLC2A2 |
SLC2A2, GLUT2: Solute carrier family 2, facilitated glucose transporter member 2 |
ITIH2 |
IPI00619918 |
0.41 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
0.41 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
0.41 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
CST7 |
CST7: Cystatin-F precursor |
0.41 |
Evidence |
|
| LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
GNB2L1 |
Lung cancer oncogene 7 |
0.41 |
Evidence |
|
| IGFBP1 |
IGFBP1, IBP1: Insulin-like growth factor-binding protein 1 precursor |
ADAM12 |
IPI00643672 |
0.41 |
Evidence |
|
| HCK |
IPI00029769 |
FCGR2A |
FCGR2A: Fc of IgG, low affinity IIa, receptor |
0.41 |
Evidence |
|
| HCK |
IPI00029769 |
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
0.41 |
Evidence |
|
| HCK |
IPI00029769 |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
0.41 |
Evidence |
|
| HCK |
IPI00029769 |
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
0.41 |
Evidence |
|
| MYL3 |
MYL3: Myosin light polypeptide 3 |
TPM1 |
IPI00296039 |
0.41 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
PON1 |
IPI00555746 |
0.41 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
TST |
TST: Thiosulfate sulfurtransferase |
0.41 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
0.41 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
HAMP |
HAMP, HEPC, UNQ487/PRO1003, LEAP1: Hepcidin precursor |
0.41 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
ORM2 |
ORM2, AGP2: Alpha-1-acid glycoprotein 2 precursor |
0.41 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
C8G |
C8G: Complement component C8 gamma chain precursor |
0.41 |
Evidence |
|
| S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
0.41 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
PON1 |
IPI00555746 |
0.41 |
Evidence |
|